Chronic Hand Eczema

Explore clinical trials studying Chronic Hand Eczema. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Chronic Hand Eczema trial results

Completed

Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials

NCT04949841

Conditions: Chronic Hand Eczema
Locations: LEO Investigational Site Brussels, Belgium

LEO Investigational Site Ghent, Belgium

LEO Investigational Site Kortrijk, Belgium

LEO Investigational Site Leuven, Belgium

View all 95 locations

View Trial Details

Completed

Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema

NCT05486117

Conditions: Chronic Hand Eczema
Locations: LEO Investigational Site Hamburg, Germany

View Trial Details

Completed

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

NCT03683719

Conditions: Chronic Hand Eczema
Locations: Leo Pharma Investigational Site Tucson, Arizona, United States

Leo Pharma Investigational Site Hialeah, Florida, United States

Leo Pharma Investigational Site Portland, Oregon, United States

Leo Pharma Investigational Site Portland, Oregon, United States

View all 28 locations

View Trial Details

Completed

Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids

NCT03861455

Conditions: Chronic Hand Eczema
Locations: Saint André Hospital Bordeaux, France

Hôpital Saint Eloi Montpellier, France

CHU Lyon-Sud Département d'allergologie et d'immunologie clinique Pierre-Bénite, France

Larrey Hospital Toulouse, France

View Trial Details

Completed

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

NCT04378569

Conditions: Chronic Hand Eczema
Locations: Arcutis Clinical Site 239 Beverly Hills, California, United States

Arcutis Clinical Site 225 Encino, California, United States

Arcutis Clinical Site 112 Fremont, California, United States

Arcutis Clinical Site 120 Irvine, California, United States

View all 37 locations

View Trial Details

Completed

Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan

NCT03246776

Conditions: Chronic Hand Eczema
Locations: Friendship Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Chronic Hand Eczema - Self-management and Prognosis

NCT01482663

Conditions: Chronic Hand Dermatitis, Chronic Hand Eczema, Dermatitis, +4 more
Locations: Dermatologic practise, Vesterbro 99 Aalborg, Denmark

Department of Dermato-Allergology, Copenhagen University Hospital Gentofte Hellerup, Denmark

View Trial Details

Chronic Hand Eczema

Chronic Hand Eczema trial results

Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials

Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan

Chronic Hand Eczema - Self-management and Prognosis

Related conditions